INCY — INCYTE CORP
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 879169 ·
Last close
$119.09
Market Cap
$24.27B
52W High
$132.60
52W Low
$89.25
ADV30
1,754,132
Next earnings
2026-10-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 1,557,204,000 | 1,448,504,000 | -707,452,000 | -784,803,000 | 7,287,257,000 | 3,275,881,000 | 1,644,320,000 |
| Jun 2026 | 1,674,039,000 | 1,569,039,000 | 700,389,000 | 585,605,000 | 7,872,647,000 | 3,982,375,000 | 1,528,220,000 |
| Mar 2026 | 1,272,676,000 | 1,168,176,000 | 324,173,000 | 303,330,000 | 7,339,113,000 | 3,461,114,000 | 1,716,266,000 |
| Dec 2025 | 1,506,835,000 | 1,385,735,000 | 383,963,000 | 299,279,000 | 6,957,973,000 | 3,097,817,000 | 1,790,495,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$744,992,000
Investing CF
$-221,750,000
Financing CF
$301,955,000
CapEx
$-65,121,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$1.88
As of
2026-11-01
Balance + Analyst (yfinance extras)
Retained Earnings
$317,901,000
Inventory
$134,252,000
Receivables
$1,237,027,000
ST Investments
$578,691,000
EBIT TTM
$798,545,000
Pretax Income TTM
$796,207,000
Interest Exp TTM
$2,338,000
Analysts
24
Yahoo Snapshot (yfinance, live)
Total Revenue
$6,010,754,048
EBITDA
$2,035,372,032
Free Cash Flow
$1,286,754,432
Enterprise Value
$20,722,233,344
Total Cash
$3,854,572,032
Total Debt
$37,412,000
Shares Out
203,832,492
Trailing EPS
$1.96
Book Value
$27.66
ROE
7.8%
ROA
17.8%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 5,141,242,000 | 1,342,790,000 | 1,286,650,000 | 6,957,973,000 | 1,790,495,000 | 5,167,478,000 | 1,413,498,000 |
| Dec 2024 | 4,241,217,000 | 101,294,000 | 32,615,000 | 5,444,322,000 | 1,996,694,000 | 3,447,628,000 | 335,337,000 |
| Dec 2023 | 3,695,649,000 | 655,358,000 | 597,599,000 | 6,782,107,000 | 1,592,270,000 | 5,189,837,000 | 496,487,000 |
| Dec 2022 | 3,394,635,000 | 591,626,000 | 340,660,000 | 5,840,984,000 | 1,470,865,000 | 4,370,119,000 | 969,941,000 |
TTM Snapshot
Revenues TTM
$5,819,530,000
NetIncome TTM
$1,612,383,000
OpCashFlow TTM
—
Assets (Latest)
$7,872,647,000
Forward EPS
$8.73
Max Pain — expiry 2026-12-18
max pain strike: $120.00 · spot: $117.80 · call oi: 4,604 · put oi: 12,517
Expected Move to 2026-12-18:
±$13.65
(11.59%) —
implied range
$104.15 –
$131.45
· ATM straddle on $120.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MEDP | Medpace Holdings, Inc. | $18.27B | $653.09 | — |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $15.92B | $332.16 | — |
| ICLR | ICON PLC | $15.05B | $195.02 | — |
| IQV | IQVIA HOLDINGS INC. | $42.45B | $257.60 | — |
| IDXX | IDEXX LABORATORIES INC /DE | $54.38B | $690.24 | — |
News headlines (Yahoo Finance, 1h cache)
Povofortay® (povorcitinib) Approved in Europe as the First Once-Daily Oral Treatment for Adults with Moderate to Severe Hidradenitis Suppurativa
2026-11-16 21:30 · Yahoo
How Incyte Trial And New Cancer Data Will Impact Natera Stock
2026-11-13 05:13 · Yahoo
Incyte Maps Post-Jakafi Growth, Targeting Up to $4 Billion in Other Sales by 2030
2026-11-11 13:12 · Yahoo
Natera and Incyte partner on Phase II colorectal cancer trial
2026-11-11 11:19 · Yahoo
Natera Announces Clinical Collaboration with Incyte on Interventional Phase II Study in Colorectal Cancer
2026-11-10 12:00 · Yahoo
Incyte to Present New Data Highlighting Progress Across its Hematology Portfolio at ASH 2026
2026-11-04 14:00 · Yahoo
Incyte to Present at Upcoming Investor Conferences
2026-11-04 13:00 · Yahoo
What Does Incyte (INCY) First Patient Dosing Mean For Its Colorectal Cancer Pipeline?
2026-10-31 22:09 · Yahoo
Incyte (INCY) Q3 2026 Earnings Call Transcript
2026-10-29 22:45 · Yahoo
Natera (NTRA) Following Clinical Momentum Looks Fully Valued To Some
2026-11-13 04:36 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.